SE9403158D0 - New use of prostaglandins - Google Patents

New use of prostaglandins

Info

Publication number
SE9403158D0
SE9403158D0 SE9403158A SE9403158A SE9403158D0 SE 9403158 D0 SE9403158 D0 SE 9403158D0 SE 9403158 A SE9403158 A SE 9403158A SE 9403158 A SE9403158 A SE 9403158A SE 9403158 D0 SE9403158 D0 SE 9403158D0
Authority
SE
Sweden
Prior art keywords
prostaglandins
new use
prostaglandin
psoriasis
treatment
Prior art date
Application number
SE9403158A
Other languages
English (en)
Swedish (sv)
Inventor
Johan Stjernschantz
Bahram Resul
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE9403158A priority Critical patent/SE9403158D0/xx
Publication of SE9403158D0 publication Critical patent/SE9403158D0/xx
Priority to DE69535081T priority patent/DE69535081T2/de
Priority to AT03000905T priority patent/ATE330613T1/de
Priority to EP95933000A priority patent/EP0778774B1/fr
Priority to ES95933000T priority patent/ES2194055T3/es
Priority to PCT/SE1995/001059 priority patent/WO1996009055A1/fr
Priority to JP51080696A priority patent/JP4044611B2/ja
Priority to DE69530303T priority patent/DE69530303T2/de
Priority to AU35817/95A priority patent/AU705901B2/en
Priority to US08/809,017 priority patent/US6031001A/en
Priority to ES03000905T priority patent/ES2263853T3/es
Priority to AT95933000T priority patent/ATE236638T1/de
Priority to EP03000905A priority patent/EP1310256B1/fr
Priority to CA002200480A priority patent/CA2200480C/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE9403158A 1994-09-21 1994-09-21 New use of prostaglandins SE9403158D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE9403158A SE9403158D0 (sv) 1994-09-21 1994-09-21 New use of prostaglandins
CA002200480A CA2200480C (fr) 1994-09-21 1995-09-19 Nouvelle utilisation de prostaglandines
JP51080696A JP4044611B2 (ja) 1994-09-21 1995-09-19 プロスタグランジンの新たな使用
AT03000905T ATE330613T1 (de) 1994-09-21 1995-09-19 Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis
EP95933000A EP0778774B1 (fr) 1994-09-21 1995-09-19 Nouvelle utilisation de prostaglandines
ES95933000T ES2194055T3 (es) 1994-09-21 1995-09-19 Nuevo uso de prostaglandinas.
PCT/SE1995/001059 WO1996009055A1 (fr) 1994-09-21 1995-09-19 Nouvelle utilisation de prostaglandines
DE69535081T DE69535081T2 (de) 1994-09-21 1995-09-19 Verwendung von Prostaglandin A oder dessen Derivaten zur Behandlung von Psoriasis
DE69530303T DE69530303T2 (de) 1994-09-21 1995-09-19 Neue verwendung von prostaglandinen
AU35817/95A AU705901B2 (en) 1994-09-21 1995-09-19 New use of prostaglandins
US08/809,017 US6031001A (en) 1994-09-21 1995-09-19 Use of prostaglandins
ES03000905T ES2263853T3 (es) 1994-09-21 1995-09-19 Uso de prostaglandina a o sus derivados para el tratamiento de la psoriasis.
AT95933000T ATE236638T1 (de) 1994-09-21 1995-09-19 Neue verwendung von prostaglandinen
EP03000905A EP1310256B1 (fr) 1994-09-21 1995-09-19 Utilisation de la prostaglandine A ou de ses dérivés pour le traitement du psoriasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9403158A SE9403158D0 (sv) 1994-09-21 1994-09-21 New use of prostaglandins

Publications (1)

Publication Number Publication Date
SE9403158D0 true SE9403158D0 (sv) 1994-09-21

Family

ID=20395309

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9403158A SE9403158D0 (sv) 1994-09-21 1994-09-21 New use of prostaglandins

Country Status (10)

Country Link
US (1) US6031001A (fr)
EP (2) EP1310256B1 (fr)
JP (1) JP4044611B2 (fr)
AT (2) ATE236638T1 (fr)
AU (1) AU705901B2 (fr)
CA (1) CA2200480C (fr)
DE (2) DE69530303T2 (fr)
ES (2) ES2194055T3 (fr)
SE (1) SE9403158D0 (fr)
WO (1) WO1996009055A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981586A (en) * 1997-05-23 1999-11-09 Pershadsingh; Harrihar A. Methods for treating proliferative and inflammatory skin diseases
SE9702681D0 (sv) * 1997-07-10 1997-07-10 Pharmacia & Upjohn Ab Method and composition for treatment of impotence
FR2773075B1 (fr) * 1997-12-31 2000-05-05 Cird Galderma Utilisation d'activateurs de ppar-gamma en dermatologie
SE9900672D0 (sv) 1999-02-25 1999-02-25 Synphora Ab Method and composition for prevention of scar formation in glaucoma filtration bleb and drainage fistula
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US6894175B1 (en) * 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
US20020013294A1 (en) * 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020037914A1 (en) * 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) * 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
ATE466577T1 (de) * 2001-05-03 2010-05-15 Cornell Res Foundation Inc Behandlung von krankheiten, die durch hpv verursacht werden
US20050159485A1 (en) * 2002-01-04 2005-07-21 Jost-Price Edward R. Combinations for the treatment of immunoinflammatory disorders and proliferative skin diseases
US20060100181A1 (en) * 2002-05-03 2006-05-11 Jost-Price Edward R Combinations for the treatment of inflammatory skin disorders
WO2003105824A1 (fr) * 2002-06-14 2003-12-24 Alcon, Inc. Utilisation topique de composes d'acide hydroxyeicosatetraenoique pour le traitement du psoriasis
SE0402029D0 (sv) * 2004-08-17 2004-08-17 Synphora Ab Prostaglandin a derivatieves for the treatment of psoriasis
KR100760430B1 (ko) * 2004-12-31 2007-10-04 한미약품 주식회사 당뇨병 치료제의 경구 투여용 서방성 복합 제제 및 이의제조 방법
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US9328060B2 (en) 2013-10-18 2016-05-03 East Carolina University J-series prostaglandin-ethanolamides as novel therapeutics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4009282A (en) * 1973-12-17 1977-02-22 The Regents Of The University Of Michigan Treatment of proliferating skin diseases with prostaglandins
DE2460285A1 (de) * 1973-12-25 1975-07-03 Ono Pharmaceutical Co Trans-delta hoch 2-prostaglandinverbindungen, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4254145A (en) * 1978-08-16 1981-03-03 American Cyanamid Company Topical application of prostaglandin hypotensive agents
JPS58216155A (ja) * 1982-06-10 1983-12-15 Ono Pharmaceut Co Ltd 新規なプロスタグランジンｄ類似化合物
DE3785602T2 (de) * 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
DE1300150T1 (de) * 1988-09-06 2003-09-18 Pharmacia Ab, Stockholm Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck
CZ277720B6 (en) * 1990-12-29 1993-03-17 Vysoka Skola Chem Tech Pharmaceutic gel containing natural prostaglandins for topic use

Also Published As

Publication number Publication date
EP0778774A2 (fr) 1997-06-18
EP1310256A2 (fr) 2003-05-14
ES2194055T3 (es) 2003-11-16
DE69530303T2 (de) 2004-02-12
EP1310256A3 (fr) 2003-06-25
ATE330613T1 (de) 2006-07-15
ATE236638T1 (de) 2003-04-15
AU3581795A (en) 1996-04-09
DE69535081T2 (de) 2007-06-28
DE69535081D1 (de) 2006-08-03
CA2200480A1 (fr) 1996-03-28
ES2263853T3 (es) 2006-12-16
AU705901B2 (en) 1999-06-03
JP4044611B2 (ja) 2008-02-06
DE69530303D1 (de) 2003-05-15
EP0778774B1 (fr) 2003-04-09
JPH10505861A (ja) 1998-06-09
WO1996009055A1 (fr) 1996-03-28
US6031001A (en) 2000-02-29
EP1310256B1 (fr) 2006-06-21
CA2200480C (fr) 2003-03-25

Similar Documents

Publication Publication Date Title
SE9403158D0 (sv) New use of prostaglandins
AU549481B2 (en) Hair growing agent
UA19303A (uk) Спосіб одержаhhя похідhих 2-аhіліhопіримідиhу
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
ATE64270T1 (de) Fungizide verwendung eines cyanopyrrol-derivates.
ATE225168T1 (de) Verwendung von lycopen zur verminderung der zellaktivität, insbesondere von krebszellen, sowie entsprechende pharmazeutische zubereitungen
MX9700273A (es) Benzamidinas sustituidas, su preparacion y empleo como sustancias medicamentosas.
TR199802060T2 (xx) Aminoisokinolinler ve aminopiridin t�revlerinin iltihap �nleyiciler olarak kullan�m�.
ATE206708T1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
AU1792700A (en) Compositions for the treatment of skin diseases
ATE43244T1 (de) Pharmazeutische zusammensetzung in form einer salbe zur dermischen und ophthalmischen verwendung.
DE69530988D1 (de) Benzimidazolderivate mit dopaminerger wirkung
ATE80616T1 (de) Prostaglandin e1-derivate und ihre therapeutische anwendung.
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
FR2434804A1 (fr) Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
ATE1146T1 (de) 3-chlor-6-hydroxy-5-methyl-benzoesaeure-derivate die entsprechenden pharmazeutischen zusammensetzungen, das wachstum bestimmter tiere stimulierende zusammensetzungen und deren herstellung.
DE69132050D1 (de) Zusammensetzungen von wachstumsfaktoren, herstellung und verwendung
SE8705035L (sv) Anvaendning av alkylglycerol
SE0402029D0 (sv) Prostaglandin a derivatieves for the treatment of psoriasis
NO169127C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt pepti
MD996G2 (ro) Metodă de tratament a cistitei
ECSP951476A (es) Benzamidinas sustituidas, su preparacion y empleo como sustancias medicamentosas
CA2089143A1 (fr) Compositions de facteur de croissance, leur preparation et leur utilisation